Clinical trial · Observational
Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer
NCT02229253CI-TRIAL-00030525completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients with prostate cancer and a history of cardiovascular disease treated with degarelix for their prostate cancer, will be followed for a period of one year. In this real-life, non-interventional trial, any cardiovascular events occurring during degarelix therapy will be documented.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Hormone Sensitive Prostate Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| degarelix | Drug | Degarelix | ALIAS |
Design
Arms and outcomes
Arms (1)
- label
- Degarelix
- description
- Treatment according to standard clinical practice.
- interventionNames
- Drug: degarelix
Primary outcomes (1)
- measure
- Cardiovascular event rate in hormone naïve prostate cancer patients with cardiovascular comorbidity at baseline, treated with degarelix in daily practice
- timeFrame
- Up to 1 year
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * Patients with prostate cancer and a history of cardiovascular disease, prescribed degarelix for the treatment of their prostate cancer Exclusion Criteria: * Patients who have received a form of androgen deprivation therapy for their prostate cancer, during the 12 months preceding this study are excluded * Planned intermittent or short-term (\< 12 months) degarelix treatment * Planned addition of, or switch to another form of androgen deprivation therapy during the study
References
Publications (0)
Data not yet available
No reference posted for this study.